Search Results 1171-1180 of 16820 for monoclonal antibody
... monoclonal antibody (e.g., rituximab) in combination with chemotherapy. Measurable disease as defined below: Fluorodeoxyglucose (FDG)-avid lymphomas ...
... monoclonal antibody, or other agents used in the study. Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection ...
Monoclonal antibodies ≤ 3 weeks; Radiation therapy ≤ 3 weeks; Anti-Her-2 directed therapy ≤ 3 weeks. Prior endoxifen therapy; Prior history of: Stroke ≤ 6 ...
It almost always starts as a relatively benign condition known as monoclonal gammopathy of undetermined significance (MGUS), which was originally identified at ...
Complement activation after binding of an IgG autoantibody ... monoclonal IgG that neutralises the complement protein C5--in neuromyelitis optica spectrum ...
Serum monoclonal protein ≥ 1.0 g/dl by protein electrophoresis;; > 200 mg of monoclonal protein in the urine on 24-hour electrophoresis;; If either serum or ...
The objectives of this study are to determine whether adequate blood volumes can be obtained with the Tasso+ device for anti-HLA antibody testing, to ...
... antibody specific for their deceased donor. It is our hypothesis that blockade of terminal complement activation with eculizumab at the time of transplant ...
Both chimeric antigen receptor (CAR)-T cell and bispecific antibody (BsAb) as T cell-directed therapies have yielded impressive clinical responses in people ...
the Second International Workshop on Waldenström macroglobulinemia. - At least 2 prior lines of treatment, including an anti-CD20 monoclonal antibody-containing ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.